Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stellate Systems was a pioneering medical technology company headquartered in Montreal, Canada, that specialized in the development of advanced neurophysiology and sleep diagnostic solutions. Founded in 1986, the company became a global leader in digital EEG (electroencephalography) and PSG (polysomnography) software, providing critical tools for the monitoring and diagnosis of epilepsy and sleep disorders. Its flagship software platform, Harmonie, was renowned for its sophisticated signal processing and data management capabilities, serving a wide range of clinical and research applications. In July 2008, Stellate Systems was acquired by Natus Medical for approximately $16 million, a move that integrated Stellate's innovative technology into Natus's extensive neurology product line. The acquisition solidified Natus's position as a dominant player in the brain monitoring and diagnostics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stellate Systems.